The DOI matches its Crossref record; 217 of the 217 references it cites were found in a registry or an index.
A proteogenomic portrait of lung squamous cell carcinoma
Open accessAbstract
Lung squamous cell carcinoma (LSCC) remains a leading cause of cancer death with few therapeutic options. We characterized the proteogenomic landscape of LSCC, providing a deeper exposition of LSCC biology with potential therapeutic implications. We identify NSD3 as an alternative driver in FGFR1-amplified tumors and low-p63 tumors overexpressing the therapeutic target survivin. SOX2 is considered undruggable, but our analyses provide rationale for exploring chromatin modifiers such as LSD1 and EZH2 to target SOX2-overexpressing tumors. Our data support complex regulation of metabolic pathways by crosstalk between post-translational modifications including ubiquitylation. Numerous immune-related proteogenomic observations suggest directions for further investigation. Proteogenomic dissection of CDKN2A mutations argue for more nuanced assessment of RB1 protein expression and phosphorylation before declaring CDK4/6 inhibition unsuccessful. Finally, triangulation between LSCC, LUAD, and HNSCC identified both unique and common therapeutic vulnerabilities. These observations and proteogenomics data resources may guide research into the biology and treatment of LSCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–217 of 217
Song, X., Ji, J., Gleason, K. J., Yang, F., Martignetti, J. A., Chen, L., & Wang, P. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.001220 · Cited by 33
Self-citationLi, P., Cao, G., Zhang, Y., Shi, J., Cai, K., Zhen, L., He, X., Zhou, Y., Li, Y., Zhu, Y., et al. (2020) · Aging · doi:10.18632/aging.102564 · Cited by 30
Self-citationMyers, S. A., Klaeger, S., Satpathy, S., Viner, R., Choi, J. H., Rogers, J. C., Clauser, K. R., Udeshi, N. D., & Carr, S. A. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00611 · Cited by 28
Self-citationGene regulatory effects of disease-associated variation in the NRF2 network
Lacher, S. E., & Slattery, M. G. (2016) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2016.09.001 · Cited by 27
Impact of acetylation on tumor metabolism
Zhao, D., Li, F.-L., Cheng, Z., & Lei, Q. (2014) · Molecular & Cellular Oncology · doi:10.4161/23723548.2014.963452 · Cited by 26
RhoGDIα Acetylation at K127 and K141 Affects Binding toward Nonprenylated RhoA
Kuhlmann, N., Wroblowski, S., Scislowski, L., & Lammers, M. (2016) · Biochemistry · doi:10.1021/acs.biochem.5b01242 · Cited by 24
Lewandowski, K. T., & Piwnica-Worms, H. M. (2013) · Journal of Cell Science · doi:10.1242/jcs.129148 · Cited by 24
Protein ISGylation and free ISG15 levels are increased by interferon gamma in breast cancer cells
Tecalco-Cruz, Á. C., & Cruz-Ramos, E. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.04.030 · Cited by 21
PANOPLY: a cloud-based platform for automated and reproducible proteogenomic data analysis
Mani, D. R., Maynard, M., Kothadia, R. B., Krug, K., Christianson, K. E., Heiman, D. I., Clauser, K. R., Birger, C., Getz, G. A., & Carr, S. A. (2021) · Nature Methods · doi:10.1038/s41592-021-01176-6 · Cited by 20
Self-citationCo-Expression Analysis Reveals Mechanisms Underlying the Varied Roles of NOTCH1 in NSCLC
Sinicropi-Yao, S. L., Amann, J. M., Lopez, D. L. Y., Cerciello, F., Coombes, K. R., & Carbone, D. P. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.10.162 · Cited by 19
Robust classification of Immune Subtypes in CancerPreprint
Gibbs, D. L. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.17.910950 · Cited by 18
Liu, W., Payne, S., Ma, S., & Fenyö, D. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.tir119.001442 · Cited by 17
Self-citationErratum: Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance
Ramadoss, S., Sen, S., Ramachandran, I., Roy, S., Chaudhuri, G., & Farias‐Eisner, R. (2017) · Oncogene · doi:10.1038/onc.2017.331 · Cited by 16
Using CART to Detect Multiple Change Points in the Mean for Large Sample
Gey, S., & Lebarbier, E. (2008) · HAL · Cited by 15
Karachaliou, N., Fernández-Bruno, M., & Rosell, R. (2018) · Translational Lung Cancer Research · doi:10.21037/tlcr.2018.07.02 · Cited by 14
Reva, B. A., Omelchenko, T., Calinawan, A. P., Nair, S. S., Schadt, E. E., & Tewari, A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.19.345629 · Cited by 5
Self-citationVats, P., Chinnaiyan, A. M., & Kumar‐Sinha, C. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9904-0_5 · Cited by 3
Self-citation
Cited by
Towards a general-purpose foundation model for computational pathology
Chen, R. J., Ding, T., Lu, M. Y., Williamson, D. F. K., Jaume, G., Song, A. H., Chen, B., Zhang, A., Shao, D., Shaban, M., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-02857-3 · Cited by 1,560
Yang, Z., Yan, C., Ma, J., Peng, P., Ren, X., Cai, S., Shen, X., Wu, Y., Zhang, S., Wang, X., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-022-00710-w · Cited by 589
Self-citationZhong, Q., Xiao, X., Qiu, Y., Xu, Z., Chen, C., Chong, B., Zhao, X., Hai, S., Li, S., An, Z., et al. (2023) · MedComm · doi:10.1002/mco2.261 · Cited by 442
Cancer proteogenomics: current impact and future prospects
Mani, D. R., Krug, K., Zhang, B., Satpathy, S., Clauser, K. R., Ding, L., Ellis, M., Gillette, M. A., & Carr, S. A. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00446-5 · Cited by 229
Self-citationModulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors
Lv, X., Lu, X., Cao, J., Luo, Q., Ding, Y., Peng, F., Pataer, A., Lu, D., Han, D., Malmberg, E., et al. (2023) · Science · doi:10.1126/science.abn4180 · Cited by 123
Self-citation
Metadata
- Authors
- Satpathy, S., Krug, K., Jean Beltran, P. M., Savage, S. R., Petralia, F., Kumar-Sinha, C., Dou, Y., Reva, B., Kane, M. H., Avanessian, S. C., Vasaikar, S. V., Krek, A., Lei, J. T., Jaehnig, E. J., Omelchenko, T., Geffen, Y., Bergstrom, E. J., Stathias, V., Christianson, K. E., Heiman, D. I., Cieslik, M. P., Cao, S., Song, X., Ji, J., Liu, W., Li, K., Wen, B., Li, Y., Gümüş, Z. H., Selvan, M. E., Soundararajan, R., Visal, T. H., Raso, M. G., Parra, E. R., Babur, Ö., Vats, P., Anand, S., Schraink, T., Cornwell, M., Rodrigues, F. M., Zhu, H., Mo, C.-K., Zhang, Y., da Veiga Leprevost, F., Huang, C., Chinnaiyan, A. M., Wyczalkowski, M. A., Omenn, G. S., Newton, C. J., Schurer, S., Ruggles, K. V., Fenyö, D., Jewell, S. D., Thiagarajan, M., Mesri, M., Rodriguez, H., Mani, S. A., Udeshi, N. D., Getz, G., Suh, J., Li, Q. K., Hostetter, G., Paik, P. K., Dhanasekaran, S. M., Govindan, R., Ding, L., Robles, A. I., Clauser, K. R., Nesvizhskii, A. I., Wang, P., Carr, S. A., Zhang, B., Mani, D. R., Gillette, M. A., Green, A., Molinolo, A., Francis, A., Paulovich, A. G., Karnuta, A., Colaprico, A., Hindenach, B., Pruetz, B. L., Kubisa, B., Druker, B. J., Huynh, C., Goldthwaite, C. A., Birger, C., Kinsinger, C. R., Jones, C. D., Rohrer, D., Valley, D. R., Chan, D. W., Chesla, D., Hansel, D., Ponomareva, E. V., Duffy, E., Burks, E., Schadt, E. E., Fedorov, E. S., An, E., Ding, F., Wilson, G. D., Batra, H., Zhang, H., Maas, J. E., Eschbacher, J., Ketchum, K. A., Rodland, K. D., Hoadley, K. A., Suzuki, K., Um, K. S., Qi, L., Bernard, L., Wiznerowicz, M., Wojtyś, M., Domagalski, M. J., Ellis, M. J., Dyer, M. A., Borucki, M., Anurag, M., Birrer, M. J., Xu, M., Krotevich, M., Roche, N., Edwards, N. J., Vatanian, N., Mucci, N. R., Maunganidze, N., Gabrovski, N., Potapova, O., Fadare, O., Grady, P., McGarvey, P. B., Hariharan, P., Thangudu, R. R., Montgomery, R., Pandurengan, R., Smith, R. D., Welsh, R. J., Mareedu, S., Payne, S. H., Cottingham, S., Singh, S., Tsang, S. X., Cai, S., Gabriel, S., Liu, T., Hiltke, T., Vashist, T., Bauer, T., Sovenko, V., Tourtellotte, W. G., Ma, W., Bocik, W., Hasan, W., Jing, X., Tang, X., Liao, Y., Yvonne, Shutack, Zhang, Z., & Hanhan, Z.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2021-08
- Volume
- 184
- Issue
- 16
- Pages
- 4348-4371.e40
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W3188077199
- Cited by
- 377
- References
- 217
- FWCI
- 19.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.